
A higher dose of phenylbutazone, commonly known as bute, may not provide horses with any additional pain relief, according to a new study from the University of Illinois published in the journal Animals. Using a single blinded observer, three different doses of intravenous bute were assessed in horses experiencing temporary foot pain. The researcher reported the following:
- The moderate and high doses produced similar results through the end of the 12-hour monitoring period
- Doubling the moderate dose provided no measurable additional benefit
- The low dose produced a statistically significant improvement in lameness compared with the placebo but only for a brief period
Source: Paulick Report, November 16, 2026. Link.
Sadly, as trainers and veterinarians attempt to avoid positive plasma drug tests for NSAIDs during competition by minimizing the doses which they use prior to competition, they may sometimes be using non-therapeutic or minimally-therapeutic dosages, inadvertently providing little-to-no analgesia but still risking gastrointestinal or renal toxicity.” – Jonathan Foreman
Image: Link.
Leave a Reply